医学
肝细胞癌
超声波
肝纤维化
肝癌
脂肪肝
病理
放射科
纤维化
内科学
疾病
作者
Liu-Liu Cao,Peng Mei,Xiang Xie,Gong-Quan Chen,Shuyan Huang,Jiayu Wang,Fan Jiang,Xin‐Wu Cui,Christoph F. Dietrich
标识
DOI:10.3748/wjg.v28.i27.3398
摘要
Artificial intelligence (AI) is playing an increasingly important role in medicine, especially in the field of medical imaging. It can be used to diagnose diseases and predict certain statuses and possible events that may happen. Recently, more and more studies have confirmed the value of AI based on ultrasound in the evaluation of diffuse liver diseases and focal liver lesions. It can assess the severity of liver fibrosis and nonalcoholic fatty liver, differentially diagnose benign and malignant liver lesions, distinguish primary from secondary liver cancers, predict the curative effect of liver cancer treatment and recurrence after treatment, and predict microvascular invasion in hepatocellular carcinoma. The findings from these studies have great clinical application potential in the near future. The purpose of this review is to comprehensively introduce the current status and future perspectives of AI in liver ultrasound.
科研通智能强力驱动
Strongly Powered by AbleSci AI